Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study

Xiaocong Li Marston, Martin Unverdorben, Yu‐Chen Yeh et al.|European Heart Journal|2020

Cited by 4